Overview

Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease

Status:
Completed
Trial end date:
2005-09-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia, Europe, and Middle East. Adult patients with chronic kidney disease are treated with growth hormone to assess effect on nutritional status.
Phase:
Phase 2
Details
Lead Sponsor:
Novo Nordisk A/S